LIPAC Oncology
Dr. Shigeo Horie is professor and chairman of Juntendo University Graduate School of Medicine. Shigeo is a key opinion leader in urology and oncology and has served as a TesoRx special advisor since 2016. He graduated from the University of Tokyo and did his research and clinical fellowship at the UT Southwestern Medical Center in Dallas. Shigeo joined the faculty of the University of Tokyo, National Cancer Center Hospital, and Kyorin University before becoming the chairman of the Department of Urology of Teikyo University in 2003.
In 2012, Shigeo was appointed as the chairman of the Department of Urology of Juntendo University. He specialized in uro-oncology, urinary dysfunction, and men’s health. He published more than 150 peer-reviewed papers.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
LIPAC Oncology
LIPAC Oncology is a pharmaceutical company focused on advancing the development of new investigational therapies to treat intracavitary cancers.